Wegovy is an FDA-approved branded product manufactured under cGMP (current Good Manufacturing Practice) standards by Novo Nordisk, with full clinical-trial data submitted to FDA
That leads to a more gradual release of glucose (sugar) into the bloodstream, triggering the production of GLP-1
Jardiance is an SGLT2 inhibitor taken orally, while Ozempic is a once-weekly GLP-1 receptor agonist injection
Education: Prescription GLP-1 vs Supplements The Evidence Gap Understanding the evidence gap between pharmaceutical interventions and dietary supplements is critical for realistic expectations
Hypothyroidism, for example, is treated with a daily pill and can remove a significant metabolic barrier once addressed
They have not been reviewed by the FDA for safety, effectiveness, or quality before marketing and are not generic equivalents of FDA-approved branded medications such as Wegovy or Ozempic